InvestorsHub Logo
Followers 33
Posts 5369
Boards Moderated 0
Alias Born 09/18/2005

Re: JoeLahr post# 111668

Saturday, 08/06/2022 11:44:01 PM

Saturday, August 06, 2022 11:44:01 PM

Post# of 113741
I believe! At least for 9-12 more months. Maybe SBFM won't cure cancer, but they found some mRNA molecules that destroy cancer cells (see below). I'll wait for more about this before deciding whether to continue holding or selling.

K1.1 Anti-cancer mRNA: In June 2021, we initiated a new research project in which we set out to determine if certain mRNA molecules can be used as anti-cancer agents. The data collected to date have shown that a selected group of mRNA molecules are capable of destroying cancer cells in vitro including multidrug resistant breast cancer cells (MCF-7/MDR), ovarian adenocarcinoma cells (OVCAR-3), and pancreatic cancer cells (SUIT-2). Other studies using non-transformed (normal) human cells (HMEC cells) showed that these mRNA molecules had little cytotoxic effects. These new mRNA molecules, bearing the laboratory name K1.1, are readily adaptable for delivery into patients using the mRNA vaccine technology. In April 2022, we filed a provisional patent application in the United States covering the subject mRNA molecules. We plan to commence mice xenograft studies within approximately the next twelve months.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News